TITLE

Prevention of Migraine in Women Throughout the Life Span

AUTHOR(S)
Tozer, Beverly S.; Boatwright, Elizabeth A.; David, Paru S.; Verma, Deepa P.; Blair, Janis E.; Mayer, Anita P.; Files, Julia A.
PUB. DATE
August 2006
SOURCE
Mayo Clinic Proceedings;Aug2006, Vol. 81 Issue 8, p1086
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Migraine is a common disorder in women. The 1-year prevalence of migraine is 18% in women compared with 6% in men. Migraine most commonly occurs during the reproductive years, affecting 27% of women 30 to 49 years of age. The predominance of this disorder and its social, functional, and economic consequences make migraine an important issue in women's health. The hormonal milieu has a substantial effect on migraine in women. An understanding of these hormonal influences in the various stages of life in females is essential to the management and prevention of migraines. This article reviews migraine prevention strategies with an emphasis on specific therapies for each stage of a woman's life.
ACCESSION #
21973049

 

Related Articles

  • Lipoic Acid Lowers Migraine Frequency, Severity. Wagner, Elizabeth // Life Extension;Jul2007, Vol. 13 Issue 7, p18 

    The article reports on the therapeutic benefits of lipoic acid based on the study conducted by scientists in Belgium. In their study, scientists demonstrate that migraine sufferers may be able to decrease the frequency and severity of headaches by supplementing with lipoic acid. Scientists also...

  • A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. Lo, Y. L.; Lum, S. Y.; Fook-Chong, S.; Siow, H. C. // Journal of Headache & Pain;Apr2010, Vol. 11 Issue 2, p175 

    Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication...

  • New Drugs May Offer Hope for Migraine Prevention.  // Neurology Reviews;Jun2014, Vol. 22 Issue 6, p20 

    The article focuses on a study conducted by Peter Goadsby, Doctor of Medicine (MD) from the University of California, San Francisco, which reveals that single intravenous dose of ALD403, monoclonal antibody targeted to calcitonin gene-related peptide, can be helpful for the prevention of migraine.

  • Topiramate.  // Reactions Weekly;6/10/2006, Issue 1105, p18 

    The article presents 2 case studies, including a 43-year-old woman along with a 57-year old woman who suffered from symptoms of palinposia while receiving treatment with topiramate for migrane prevention, which decreased in frequency while ingesting lower doses but recurred on taking higher doses.

  • BOTOX (ONABOTULINUMTOXINA) FDA APPROVED AS PROPHYLACTIC TREATMENT OPTION FOR ADULT CHRONIC MIGRAINE SUFFERERS.  // Psychiatry (1550-5952);Oct2010, Vol. 7 Issue 10, p11 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) on Botox onabotulinumtoxinA from Allergan Inc. for the prophylactic treatment of headaches in adults with chronic migraine. It notes that the approval was based on the data collected in the company's Phase III...

  • Sustained-Release Niacin for Prevention of Migraine Headache. Velling, David A.; Dodick, David W.; Muir, Jesse J. // Mayo Clinic Proceedings;Jun2003, Vol. 78 Issue 6, p770 

    Considerable advances in the diagnosis and treatment of migraine headache have occurred during the past decade, but treatment options for acute migraine attacks have expanded at a faster rate than those for prophylaxis. We describe a patient whose migraine headaches responded dramatically to...

  • Outsmarting the migraine. Picker, Lauren // Harper's Bazaar;Oct96, Issue 3419, p162 

    Provides information on how to prevent and reduce the pain brought about by migraine. Foods that should be avoided to prevent migraine; Information about the diet of a person with migraine; Options that a person have when the precautionary measures in migraine is ineffective; Over-the-counter...

  • Divalproex is approved for prevention of migraines. Cerrato, Paul L. // RN;Aug96, Vol. 59 Issue 8, p65 

    Reports on the approval of the Food and Drug Administration on the release of Divalproex used for the prevention of migraines. Recommended starting dose; Adverse reactions.

  • Efficacy and tolerability of STOPAIN for a migraine attack. St. Cyr, Andrea; Chen, Ashley; Bradley, Kathleen C.; Yuan, Hsiangkuo; Silberstein, Stephen D.; Young, William B. // Frontiers in Neurology;Feb2015, Vol. 6, p1 

    Objective: To determine whether topical menthol 6% gel will relieve a migraine attack. Materials and Methods: A single-center, open-label pilot trial of 25 patients with at least 1 year of diagnosed episodic migraine and <15 headache days per month. Patients treated one migraine attack with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics